Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B T Hyman

Showing results (41-50 of 261) with videos related to

Pageof 27
Sort By:
Brain Research|July 22, 1996
Immunohistochemical localization of tissue factor pathway inhibitor-1 (TFPI-1), a Kunitz proteinase inhibitor, in Alzheimer's diseaseR D Hollister, W Kisiel, B T Hyman
Journal of Neuropathology and Experimental Neurology|November 1, 1993
The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolutionB T Hyman, K Marzloff, P V Arriagada
Archives of Neurology|May 18, 2000
Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer diseaseB T Hyman, D Strickland, G W Rebeck
The American Journal of Pathology|February 1, 1996
Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's diseaseR H Christie, M Freeman, B T Hyman
Trends in Neurosciences|April 1, 1993
Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?M F Beal, B T Hyman, W Koroshetz
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1985
Effect of naltrexone on senile dementia of the Alzheimer typeB T Hyman, P J Eslinger, A R Damasio
Biochimica Et Biophysica Acta|November 12, 1982
Prostaglandin production by 3T3-L1 cells in cultureB T Hyman, L L Stoll, A A Spector
The American Journal of Pathology|January 6, 2001
beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with agingM C Irizarry, J J Locascio, B T Hyman
Journal of Neuropathology and Experimental Neurology|January 1, 1995
Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zoneS D Harr, N A Simonian, B T Hyman
Neuroscience|July 29, 1998
Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization studyK J Page, R D Hollister, B T Hyman
Pageof 27

Showing results (41-50 of 261) with videos related to

Sort By:
Pageof 27
Brain Research|July 22, 1996
Immunohistochemical localization of tissue factor pathway inhibitor-1 (TFPI-1), a Kunitz proteinase inhibitor, in Alzheimer's diseaseR D Hollister, W Kisiel, B T Hyman
Journal of Neuropathology and Experimental Neurology|November 1, 1993
The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolutionB T Hyman, K Marzloff, P V Arriagada
Archives of Neurology|May 18, 2000
Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer diseaseB T Hyman, D Strickland, G W Rebeck
The American Journal of Pathology|February 1, 1996
Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's diseaseR H Christie, M Freeman, B T Hyman
Trends in Neurosciences|April 1, 1993
Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?M F Beal, B T Hyman, W Koroshetz
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1985
Effect of naltrexone on senile dementia of the Alzheimer typeB T Hyman, P J Eslinger, A R Damasio
Biochimica Et Biophysica Acta|November 12, 1982
Prostaglandin production by 3T3-L1 cells in cultureB T Hyman, L L Stoll, A A Spector
The American Journal of Pathology|January 6, 2001
beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with agingM C Irizarry, J J Locascio, B T Hyman
Journal of Neuropathology and Experimental Neurology|January 1, 1995
Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zoneS D Harr, N A Simonian, B T Hyman
Neuroscience|July 29, 1998
Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization studyK J Page, R D Hollister, B T Hyman
Pageof 27